Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 10, 2015, Pages 1738-1744.e2

  Lim, Hyun ^a   Park, Young Soo ^a   Lee, Jeong Hoon ^a   Son, Da Hye ^a   Ahn, Ji Yong ^a   Choi, Kwi Sook ^a   Kim, Do Hoon ^a   Choi, Kee Don ^a   Song, Ho June ^a   Lee, Gin Hyug ^a   Jung, Hwoon Yong ^a   Kim, Jin Ho ^a   Yook, Jeong Hwan ^a   Kim, Byung Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Carcinogenesis; Prognostic Factors; Stomach Cancer; Viral Infection

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GASTRIC CARCINOMA WITH LYMPHOID STROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PERINEURAL INVASION; PREVALENCE; RETROSPECTIVE STUDY; SEX; SOUTH KOREA; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR CELL; CARCINOMA; COMPLICATION; LYMPHOMA; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84941748831     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.04.015     Document Type: Article

References (24)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Ferlay J., Soerjomataram I., Dikshit R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015, 136:E359-E386.
3. Tsugane S., Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007, 10:75-83.
4. Murphy G., Pfeiffer R., Camargo M.C., et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009, 137:824-833.
5. Lee J.H., Kim S.H., Han S.H., et al. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol 2009, 24:354-365.
6. Burke A.P., Yen T.S., Shekitka K.M., et al. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990, 3:377-380.
7. Watanabe H., Enjoji M., Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer 1976, 38:232-243.
8. Nakamura S., Ueki T., Yao T., et al. Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 1994, 73:2239-2249.
9. Corvalan A., Ding S., Koriyama C., et al. Association of a distinctive strain of Epstein-Barr virus with gastric cancer. Int J Cancer 2006, 118:1736-1742.
10. Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000, 53:255-261.
11. Song H.J., Srivastava A., Lee J., et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology 2010, 139:84-92.e82.
12. Chang M.S., Kim W.H., Kim C.W., et al. Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Histopathology 2000, 37:309-315.
13. AJCC Cancer Staging Manual 2010, American Joint Committee on Cancer, Springer, New York. 7th ed.
14. Lauwers G., Carneiro F., Graham D. Gastric carcinoma. Classification of tumours of the digestive system 2010, IARC, Lyon. F. Bowman, F. Carneiro, R. Hruban (Eds.).
15. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011, 14:113-123. Japanese Gastric Cancer Association.
16. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014, 513:202-209. Cancer Genome Atlas Research Network.
17. Liang Q., Yao X., Tang S., et al. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer. Gastroenterology 2014, 147:1350-1362.e1354.
18. Tobo T., Hirahashi M., Yao T., et al. Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infection. Mol Clin Oncol 2013, 1:220-224.
19. van Beek J., zur Hausen A., Klein Kranenbarg E., et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol 2004, 22:664-670.
20. Wu M.S., Shun C.T., Wu C.C., et al. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology 2000, 118:1031-1038.
21. Camargo M.C., Kim W.H., Chiaravalli A.M., et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 2014, 63:236-243.
22. Huang K.H., Wang R.F., Yang M.H., et al. Advanced gastric cancer patients with lymphoid stroma have better survival than those without. J Surg Oncol 2013, 107:523-528.
23. Matsunou H., Konishi F., Hori H., et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 1996, 77:1998-2004.
24. Murray P.G., Billingham L.J., Hassan H.T., et al. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999, 94:442-447.